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A B S T R A C T
Background
Trachoma remains amajor cause of avoidable blindness among underprivileged populations inmany developing countries. It is estimated
that about 146 million people have active trachoma and nearly six million people are blind due to complications associated with repeat
infections.
Objectives
The objective of this review was to assess the effects of face washing on the prevalence of active trachoma in endemic communities.
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2011, Issue
8), MEDLINE (January 1950 to September 2011), EMBASE (January 1980 to September 2011), Latin American and Caribbean
Health Sciences Literature Database (LILACS) (January 1982 to September 2011), the metaRegister of Controlled Trials (mRCT) (
www.controlled-trials.com) and ClinicalTrials.gov (www.clinicaltrials.gov). There were no date or language restrictions in the electronic
searches for trials. The electronic databases were last searched on 2 September 2011. We checked the reference list of the included trials
to identify further relevant trials. We used the Science Citation Index to search for references that cite the studies that are included in
the review. We also contacted investigators and experts in the field to identify additional trials.
Selection criteria
We included randomized or quasi-randomized controlled trials, comparing face washing with no treatment or face washing combined
with antibiotics against antibiotics alone. Participants in the trials were people normally resident in endemic trachoma communities.
Data collection and analysis
Two review authors independently extracted data and assessed trial quality. Study authors were contacted for additional information.
Two clinically heterogeneous trials are included, therefore a meta-analysis was considered inappropriate.
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Main results
This review included two trials with data from a total of 2560 participants. Face washing combined with topical tetracycline was
compared to topical tetracycline alone in three pairs of villages in one trial. The trial found a statistically significant effect for face washing
combined with topical tetracycline in reducing ’severe’ active trachoma compared to topical tetracycline alone. No statistically significant
difference was observed between the intervention and control villages in reducing (’non-severe’) active trachoma. The prevalence of
clean faces was higher in the intervention villages than the control villages and this was statistically significant. Another trial compared
eye washing to no treatment or to topical tetracycline alone or to a combination of eye washing and tetracycline drops in children with
follicular trachoma. The trial found no statistically significant benefit of eye washing alone or in combination with tetracycline eye
drops in reducing follicular trachoma amongst children with follicular trachoma.
Authors’ conclusions
There is some evidence that face washing combined with topical tetracycline can be effective in reducing severe trachoma and in
increasing the prevalence of clean faces. Current evidence does not however support a beneficial effect of face washing alone or in
combination with topical tetracycline in reducing active trachoma.
P L A I N L A N G U A G E S U M M A R Y
Face washing promotion for reducing active trachoma
Trachoma is an infectious eye disease. Active infection usually begins in childhood and is characterized by eye discharge, redness and
irritation. Poor facial hygiene can lead to the disease spreading from person to person through eye-seeking flies or contaminated fingers.
Face washing is promoted as part of the World Health Organization ’ SAFE’ strategy to eliminate blindness around the world. The
review authors identified two randomized controlled trials with a total of 2560 participants set in Australia and Tanzania. One trial
had face washing in combination with tetracycline as the intervention and tetracycline ointment alone as the control. The second trial
compared eye washing to no treatment or to topical tetracycline alone or to a combination of eye washing and tetracycline drops in
children with follicular trachoma. Both trials reported on active trachoma as an outcome measure but only one trial reported on severe
trachoma and percentage of clean faces. The trials included in this review evaluated the effect of face washing over a three to 12 month
period. There is some evidence that face washing combined with topical tetracycline can be effective in reducing severe trachoma and
in increasing the prevalence of clean faces.
B A C K G R O U N D
Epidemiology
Trachoma is an infective eye disease caused by the microorganism
Chlamydia trachomatis. Trachoma remains amajor cause of avoid-
able blindness among underprivileged populations in many areas
of Africa, Asia and the Middle East, where poverty, overcrowding,
poor personal and environmental hygiene favor transmission of
the disease. It is estimated that about 146 million people have ac-
tive trachoma and nearly six million people are blind due to com-
plications associated with repeat infections (WHO 1997a). The
organism causing trachoma is spread from person to person by
close contact in overcrowded living conditions, or through con-
taminated fingers or cloths used by mothers to wipe away dis-
charges on the faces of children (ICEH 1999). Flies, which are
attracted to eye and nasal secretions on the faces of infected chil-
dren, are also believed to be risk factors in the transmission of the
organism (ICEH 1999; West 1991).
Presentation
In communities where trachoma is endemic, infection usually be-
gins in childhood and repeat episodes of infection cause distortion
of the eyelids (entropion), in-turned eyelashes (trichiasis), corneal
abrasion and ultimately blindness due to corneal opacity. Active
trachoma is more commonly observed in children (Taylor 1985;
West 1991). It is characterized by redness and discharge associ-
ated with inflammatory thickening of the upper tarsal conjunctiva
(mucous membrane lining the inner surface of the upper eyelids)
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and follicles (whitish elevations within the conjunctiva). A simpli-
fied grading system for the assessment of trachoma and its com-
plications in endemic communities has been published (Thylefors
1987) and discussed in a Cochrane review of antibiotics for tra-
choma (Evans 2011).
The role of face washing in trachoma control
Face washing is promoted by the World Health Organization
(WHO) program for the global elimination of trachoma as part
of the ’SAFE’ strategy (WHO 1997b; WHO 1999). The SAFE
strategy consists of surgery for trichiasis; antibiotics for infec-
tious trachoma; facial cleanliness to reduce transmission; and
environmental improvements (household sanitation andprovision
of clean water). The face washing component of this strategy aims
to maintain clean faces in the community in order to reduce eye-
seeking flies and person-to-person transmission of the trachoma
organism. Face washing promotion as a community intervention
can be combined with mass treatment with antibiotics in areas
with high trachoma endemicity. Mass treatment with antibiotics
aims to reduce the reservoir of Chlamydia trachomatis in the com-
munity while face washing aims to interrupt the cycle of infection
and re-infection in the long term. The antibiotic and environ-
mental arms of the SAFE strategy have been examined in other
published Cochrane reviews (Evans 2011; Rabiu 2012).
Rationale for a systematic review
The facewashingprinciple appears simple and theoretically sound,
but whether this intervention can reduce transmission of trachoma
in practice is now a focus of debate (Bailey 2001). Some narrative
reviews of the literature have suggested that facial cleanliness may
be useful in preventing trachoma (Emerson 2000; Pruss 2000).
However, most of the data were obtained from observational stud-
ies and the methodological quality of the few controlled trials in-
cluded was not reported. In this review we aim to summarize sys-
tematically, research evidence from trials of face washing promo-
tion for preventing active trachoma in endemic communities. In
communities where water is scarce, the uptake and practice of face
washing may not be as good as in communities where water is
freely available. The potential influence of water availability on
outcomes will be considered in this review.
O B J E C T I V E S
The objective of this review was to assess the effects of face wash-
ing promotion on the prevalence of active trachoma in endemic
communities.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized and quasi-randomized controlled trials.
Types of participants
Participants in the trials were people normally resident in com-
munities where trachoma is endemic.
Types of interventions
We considered the following interventions:
1. face washing promotion versus no intervention;
2. face washing promotion plus mass antibiotic treatment versus
mass antibiotic treatment alone.
Face washing promotion can be delivered by any means appro-
priate to the local setting such as: radio or television; health edu-
cation leaflets; community leaders; religious gatherings; role-play;
drama in village halls; school teachers; women groups; music etc.
In trials where promotion of face washing was combined with
mass antibiotic treatment, antibiotics considered include tetracy-
cline ointment or capsules; azithromycin; or erythromycin, given
at any dose or frequency.
Types of outcome measures
We considered the following outcomes.
1. Number of participants with active trachoma (TF or TI) at
6, 12, or greater than 12 months post-treatment allocation (age
group as reported in trials).
Active trachoma was defined using the Thylefors 1987 scale. On
this scale, active trachoma is categorized as TF or TI. TF is tra-
choma follicular inflammation and is defined as the presence of
five or more follicles, each of which is at least 0.5 mm in diameter,
on the flat surface of the upper tarsal conjunctiva. TI is trachoma
intense inflammation and is defined as the presence of marked
inflammatory thickening of the upper tarsal conjunctiva that ob-
scures more than half of the deep conjunctival vessels.
We planned to include trials that used other trachoma grading
scales to assess active trachoma, provided the scales used can be
related to the Thylefors 1987 scale.
2. Number of participants with an unclean face at 6, 12, or greater
than 12 months post treatment allocation (age group as reported
in trials).
An unclean face was defined as the presence of eye or nasal dis-
charge (WHO 2001) or any other definition used in trials.
3. Number of participants with severe trachoma.
Severe trachoma was not exclusively specified as an outcome in
the protocol for this review. However, we felt it was important to
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report it since one of the two trials that met the inclusion criteria
defined and reported this outcome.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) 2011, Issue 8, part of The Cochrane Li-
brary. www.thecochranelibrary.com (accessed 2 September 2011),
MEDLINE (January 1950 to September 2011), EMBASE (Jan-
uary 1980 to September 2011), Latin American and Caribbean
Health Sciences Literature Database (LILACS) (January 1982
to September 2011), the metaRegister of Controlled Trials
(mRCT) (www.controlled-trials.com) and ClinicalTrials.gov (
www.clinicaltrials.gov). There were no date or language restric-
tions in the electronic searches for trials. The electronic databases
were last searched on 2 September 2011.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1), MEDLINE (Appendix 2), EMBASE (Appendix
3), LILACS (Appendix 4), mRCT (Appendix 5) and ClinicalTri-
als.gov (Appendix 6).
Searching other resources
Trachoma experts thatwere contacted for potentially relevant stud-
ies include Hedley Peach and Sheila West. Denise Mabey was a
peer reviewer and she provided information on potentially relevant
studies. Existing reviews were identified and their citations were
checked for relevant trials. We used the Science Citation Index to
search for references that cite the studies that are included in the
review.
Data collection and analysis
Selection of studies
Two review authors independently screened titles and abstracts
found by the electronic searches. We retrieved for further assess-
ment hard copies of trials that were potentially relevant to the
review. Those that met the selection criteria were assessed for
methodological quality. Disagreements were resolved by discus-
sion.
Assessment of methodological quality
Two review authors independently assessed included trials using
the following criteria based on Chapter 8 of the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011):
1. Concealment of allocation: high, low, or unclear risk of bias. For
trials with unclear concealment of allocation, further information
was sought from primary investigators.
2. Baseline comparability between intervention and control groups
with respect to prevalence of active trachoma: low risk of bias if no
substantial differences present; unclear risk of bias if not reported
or not known whether substantial differences exist; high risk of
bias if substantial differences exist.
3. Comparability between intervention and control groups with
respect to follow up: low risk of bias if no substantial differences in
follow-up rates; unclear risk of bias if not reported or not known;
high risk of bias if substantial differences exist in follow-up rates.
4. Intention-to-treat analysis: low risk of bias if performed; unclear
risk of bias if not known; high risk of bias if not performed.
Masking of participants and providers were not used to assess
trial quality in this review. The nature of the intervention made it
difficult to successfully apply masking. Post hoc we decided to use
masking of outcome assessors as a parameter of quality.
Data collection
Two review authors independently extracted data onto a standard-
ized data extraction form. We compared extracted data and rec-
onciled differences. Disagreements were resolved by a third review
author. Where studies reported the outcomes in different ways,
primary investigators were contacted for further information to
allow transformation of data.
Data analysis
Only two trials met the inclusion criteria for this review and these
used different interventions andmethods for outcome assessment.
Ameta-analysis was considered inappropriate and a narrative sum-
mary of results is presented. If additional studies become available
in the future we will use the following methods:
The specified outcomes are dichotomous therefore only relative
risks will be calculated. Data will be combined in a meta-analysis
if appropriate, using the random-effects model. If there are fewer
than three studies and little evidence of heterogeneity a fixed-ef-
fect model will be used. In analyzing cluster-randomized trials, if
we encounter trials where the units of allocation and analysis are
different (i.e. the unit of allocation was the community and the
unit of analysis was individuals in the community) and this has
not been accounted for in the analysis, we will contact primary
investigators for additional data to develop estimates of intraclus-
ter correlation coefficients or design effect to calculate more ap-
propriate confidence intervals. If a meta-analysis is not possible, a
tabulated summary of results will be presented.
We will not rely on statistical significance of a chi squared test to
indicate heterogeneity but will consider this at all times during the
review. The existence of heterogeneity may be apparent on visual
examination of the forest plot. If present, heterogeneity will be
explored using the following subgroups:
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1. Communities with available water supply versus communities
with scarce water supply.Water availability is defined in this review
as the presence of a functional water source within 30 minutes
walk or a distance of less than four kilometers from all households
within the community (WHO 2001) or any other definition used
in the trials.
2. Communities with intense active trachoma versus communi-
ties with less intense active trachoma. Intense active trachoma is
defined in this review as communities with a baseline prevalence
of TF or TI equal to or greater than 20%, while less intense is
defined as communities with a prevalence of TF or TI less than
20% (WHO 1997b).
If possible we will conduct a sensitivity analysis to investigate the
influence of studieswith quasi-randommethods and thosewithout
concealment of allocation on the overall estimates of effect.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
The electronic searches generated 67 citations and abstracts. These
were screened and the full text of two potentially relevant articles
were retrieved for further assessment. One of these met the criteria
for inclusion (West 1995). The other was not a randomized con-
trolled trial and therefore not included in the review (Sutter 1983).
A trachoma research expert drew our attention to a randomized
trial that was not published in a journal (Peach 1987). In all two
randomized trials are included in the review.
Updated searches
An updated search done in October 2007 identified 66 new re-
ports of trials. The Trials Search Co-ordinator scanned the search
results and removed any references which were not relevant to the
scope of the review. The full text of three articles were checked
for potential inclusion, however all were excluded. Edwards 2006
and Rubinstein 2006 were reports of health education promotion
of face washing and Khandekar 2006 treated face washing and
environmental sanitation interventions as one outcome.
In September 2011 the electronic searches identified 91 additional
references. One study underwent full-text assessment (King 2011)
but was excluded as it evaluated a standardized definition of a clean
face for trachoma prevention.
Included studies
See ’Characteristics of included studies’ for further details.
Setting and participants
This review includes data from a total of 2560 participants in two
trials. West 1995 was undertaken in Kongwa, Tanzania. In this
trial a total of 1417 children, aged one to seven years from six
villages, were randomized in three pairs to intervention or control.
Peach 1987 was undertaken in theNorthernTerritory of Australia.
In this trial 36 aboriginal communities were randomized to one
of three intervention arms or one control arm. A total of 2530
children aged five to 14 were screened for follicular trachoma. A
few more children above the age of 14 and some of preschool age
were also screened. Of the total number of children screened in
the participating communities, only 1143 children with follicular
trachoma were recruited into the trial.
Interventions
InWest 1995, 680 children from three villages were randomized to
face washing promotion combined with tetracycline and 737 chil-
dren from three villages were randomized to tetracycline ointment
alone. Face washing promotion was community based and con-
sisted of neighborhood meetings to build consensus for increasing
facewashing and reinforcement activities such as school plays, sem-
inars with the traditional healers and meetings with other village
groups. Face washing promotion was carried out for one month
during and after mass treatment with tetracycline. Tetracycline
ointment was administered topically once daily for 30 days.
In Peach 1987, 374 were randomized to tetracycline eye drops,
246 children were randomized to eye washing, 312 children were
randomized to eye washing combined with tetracycline eye drops,
and 211 children were randomized to the no treatment group.
Children in the eye washing group had their eyes washed daily
by school teachers for three months. Those in the tetracycline
group had tetracycline eye drops applied daily for one week every
month for three months. For the purpose of this review, data for
the comparison between eye washing versus no treatment, and
eye washing combined with eye drops versus eye drops alone are
reported.
Outcome measures
In West 1995, outcomes reported include active trachoma, se-
vere trachoma and clean faces. Trachoma was graded using the
Thylefors 1987 scale. Severe trachoma was defined exclusively in
the trial as 15 or more follicles, or the presence of inflammation
that obscured all vessels of the tarsal plate.We extrapolated and ex-
tracted data from graphs presented in the report of the trial, as raw
data were unavailable. These extrapolated data should be regarded
as best approximations to the true figures. Our protocol specified
’unclean faces’ as the outcome of interest, but this was reported as
’clean faces’ in this trial. We have elected to present the outcome
as reported in the trial as it would be difficult to transform the
data without sufficient information from the trialists.
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In Peach 1987, outcomewas reported as the proportion of children
with follicular trachoma who had follicles at threemonths after the
intervention. The Aboriginal Health Workers simplified grading
scheme was used to assess the presence of follicles as indicating
active trachoma. Although this scale can be crudely compared
to the TF grading on the Thylefors scale, it may have a lower
specificity because of the tendency to classify participants with
fewer than five follicles as having active trachoma.
Excluded studies
See Characteristics of excluded studies for further details.
Risk of bias in included studies
In West 1995 there was no information on how randomization
was completed and whether allocation of villages to intervention
or control was concealed. Baseline prevalences in active trachoma
between comparison villages were not substantially different. Al-
though 92% of the enrolled participants were followed up for one
year, information regarding similarity of follow-up rates between
comparison groups was not provided in the report. Information
on whether analysis of results was based on an intention to treat
principle was not provided in the report. We note that this trial
masked outcome assessment by taking photographs of tarsal plate
read by an examiner who was not aware of the randomization sta-
tus of the villages.
In Peach 1987, details of how randomization was completed and
concealment of allocation were not available in the report. Addi-
tional information from the author reveals that a random num-
ber table was used to allocate communities to the interventions or
control group. The allocation was done after the initial screening
by someone who was unaware of the prevalence of trachoma and
unfamiliar with the communities, including their school teachers
and health workers. It is unclear whether baseline prevalence of
trachoma was similar among the comparison groups. Information
on the number of communities randomized to each experimental
group was not available in the report. However, during further
correspondence the authors suggest that about nine communities
were randomized to each arm. Almost 89% of enrolled partici-
pants were followed up for three months. All participants lost to
follow up were assumed to have follicles at the end of the study
and the intention to treat principle was applied in the analysis
of results. Outcome was assessed by trachoma workers who were
unaware of treatment allocation to the communities. Steps were
taken to ensure that the outcome assessors did not learn which
groups the communities were allocated to.
Table 1 gives the results of the assessment of methodological qual-
ity of the included trials.
Effects of interventions
The two trials included were different in several respects, partic-
ularly with regard to types of intervention and definition of out-
come measures. Therefore a meta-analysis was not considered ap-
propriate. A narrative summary of the results is presented.
Active trachoma (follicular or TF or TI)
In West 1995, face washing combined with antibiotics was com-
pared to antibiotics alone in three pairs of villages. In pair one,
the percentage prevalence of active trachoma was lower in the vil-
lage that received a combination of face washing and antibiotics
than the village that received antibiotics alone at 12 months fol-
low up (approximately 55% compared to 60%). In a second pair
of villages, the percentage of active trachoma was also lower in
the combination village than the antibiotic alone village (approx-
imately 40% compared to 50%). However in a third pair of vil-
lages, the percentage of active trachoma in the combination village
was higher than the antibiotics alone village (approximately 70%
compared to 65%). The overall results for all the combination vil-
lages compared to the antibiotics alone villages suggest a reduction
in the odds of any trachoma but this effect was not statistically
significant (odds ratio (OR) 0.81, 95% confidence interval (CI)
0.42 to 1.59).
In Peach 1987, 191/246 children (77.6%) in the eye washing arm
had follicles at three months compared to 160/211 (75.8%) in
the no treatment arm. The difference was not statistically signif-
icant (P = 0.73). In the eye washing/eye drop combination arm,
215/312 (68.9%) had follicles at three months compared to 250/
374 (66.8%) in the eye drop only arm. The difference was not
statistically significant (P = 0.62). When a logit model was fitted
to the data, taking age of participants, geographical location and
trachoma outcome assessors into account, the results show that the
odds of having follicular trachoma was higher in the eye drop only
arm compared to the eye washing-eye drop combination (odds
1.17 to 1.00) but these odds were not significantly greater than
1). The odds of having follicular trachoma in the no treatment
group compared to the eye washing group were similar (odds 1.02
to 1.00).
Severe trachoma
InWest 1995 the three pairs of villages were also comparedwith re-
spect to prevalence of severe trachoma. In pair one, the percentage
prevalence of severe trachomawas lower in the village that received
a combination of face washing and antibiotics than the village that
received antibiotics alone at 12 months follow up (approximately
8% compared to 14%). In a second pair of villages, the percent-
age of active trachoma was also lower in the combination village
than the antibiotic alone village (approximately 6% compared to
14%). However in a third pair of villages, the percentage of active
trachoma in the combination village was slightly higher than the
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antibiotics alone village (approximately 10% compared to 8%).
The overall results after adjustments for age and baseline trachoma
status suggests a reduction in the odds of severe trachoma by the
face washing antibiotic combination compared to antibiotic alone
and this effect was statistically significant (OR 0.62, 95% CI 0.40
to 0.97). At six months follow up, there were no differences in
the prevalence of severe trachoma between the intervention and
control groups in the three pairs of villages.
Peach 1987 did not report this outcome.
Clean faces
In West 1995 the percentage of children with clean faces was
consistently higher in the face washing-antibiotic combination
villages than the antibiotic alone villages. Total results showed an
increase in the percentage of children with clean faces in the face
washing/antibiotic combination villages from 18% at baseline to
33% at six months and 35% at 12 months follow up. There was
a smaller increase in the percentage of children with clean faces in
the antibiotic alone group (from 19% at baseline to 30% at six
months and 26% at 12 months). The difference in the proportion
of children with clean faces in the intervention villages compared
to the control villages was statistically significant (P < 0.05).
Peach 1987 did not report this outcome.
D I S C U S S I O N
Although two trials are included in this review, a meta-analysis
was not performed. This was because of notable clinical hetero-
geneity between the two trials, particularly with regard to inter-
vention strategies and outcome definition. Although the report of
the design and conduct of both trials suggests notable efforts by
the investigators to strengthen the quality, lack of adequate infor-
mation made it impossible objectively to assess the trials against
some key quality parameters specified in the review (see section on
methodological quality and additional Table 1). Outcomes were
reported at three months in Peach 1987. Although the follow-up
period fell short of what was specified in our protocol, we did not
exclude the data from this trial in view of the paucity of random-
ized trials.
Active trachoma
It is unclear why face washing promotion combined with tetra-
cycline had an effect in reducing active trachoma in two pairs of
villages but no effect in a third pair in West 1995. Differences in
baseline characteristics such as prevalence of trachoma, intensity
of transmission, availability or access to water supplies between
the third pair and the first two pair of villages may be important in
explaining the differences in benefit. However, the overall results
for the face washing/tetracycline combination villages compared
to the tetracycline only villages suggest amodest beneficial effect of
face washing in reducing active trachoma at 12 months, although
this was not statistically significant.
Peach 1987 suggests no benefit for face washing compared with no
treatment. The raw data also show no benefit for the face washing/
eye drops combination in comparison to eye drops alone. The age
of participants varied and the authors observed a higher proportion
of severe trachoma among older children. There were variations in
the prevalence of trachoma in the different geographical locations
from which the participating communities were drawn as well as
slight differences in the diagnostic competence of outcome asses-
sors. The authors hypothesised that community randomization as
done in the trial may not have adequately controlled for these fac-
tors hence the need to account for them in the logit model. After
fitting the data to a logit model to control for perceived imbal-
ances in the ages of participants, geographical location and out-
come assessors, a marginal but not statistically significant benefit
is suggested for the face washing/eye drops combination over the
eye drops alone group. The report however does not state whether
the analysis of results in a logit model was planned in advance or
simply informed by the apparent lack of effect suggested by the
raw data.
The lack of effect of face washing in Peach 1987 can be explained
by a number of factors. Firstly, the trachoma grading system used
in the trial can potentially influence the results. Participants were
recruited into the trial on the basis of whether follicles or papillae
were present. Based on this definition, participants with follicles/
papillae from causes other than active trachoma could have been
included. For this group of people, treatmentwould appear to have
no benefit if what is being treated is not trachoma. Furthermore,
if participants had trachoma which was not intense, the effect of
the face washing may not be readily apparent. Secondly, in analyz-
ing the results using the intention to treat principle, the authors
assumed that the participants lost to follow up had follicular tra-
choma at the end of the study. If this assumption was inaccurate
and there were more participants lost to follow up in a treatment
group compared to control, as was the case with the eye wash-
ing arm (17% versus 10.4%), treatment might appear to be inef-
fective compared to control. However, a sensitivity analysis with
the missing participants excluded from analysis did not alter the
results. Thirdly, the intervention was administered for only three
months. A longer intervention period and follow up may have sig-
nificantly altered the results. Fourthly, in Peach 1987, face wash-
ing was applied to children with already established disease rather
than the whole population at risk, and outcome was measured in
this group of children. The face washing strategy aims to reduce
active trachoma in endemic communities mainly by reducing the
transmission of the disease. A better measure of effect would have
been to evaluate the magnitude of the disease amongst the whole
population or subset of the population rather than amongst per-
sons with the disease, or to determine the number of new cases
of disease since institution of the intervention. It is also unclear
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how much impact on transmission can be achieved by applying
face washing only to individuals with the disease in endemic com-
munities. The true impact of face washing on active trachoma in
the communities might be better evaluated by a study design in
which face washing is applied to whole populations at risk rather
than only those with the disease.
Severe trachoma
As for active trachoma, benefits of face washing in reducing the
prevalence of severe trachomawere apparent in the first and second
pairs of villages in West 1995 at 12 months follow up. In the third
pair, there appeared to be no benefit. The overall results for all the
villages after adjusting for age and baseline trachoma status showed
a benefit of face washing in reducing severe trachoma in the in-
tervention villages compared to the control villages at 12 months
follow up. It is probable that participants with severe active tra-
choma represent a subgroup with more intense transmission and
therefore face washing, which aims to break transmission, would
be more likely to show a stronger effect within this subgroup. On
the other hand, the appropriateness of combining the results from
the three pairs of villages is questionable, since presumably the
villages were paired because of some differences between them. It
is unclear why face washing showed no comparative benefit in the
three pairs of villages at six months follow up. Apparent benefit
at 12 months underscores the importance of a longer follow-up
period to demonstrate impact of the intervention.
Clean faces
Wenote with interest that the percentage of participants with clean
faces increased in both intervention and control groups over 12
months, even though the increase was higher in the intervention
group. However, a statistically significant difference in the per-
centage of clean faces between the intervention and control groups
at 12 months suggests a benefit of face washing promotion.
Previous narrative reviews of the literature have reported possible
beneficial effects of face washing in preventing active trachoma.
The conclusions of these narrative reviews were based on data ob-
tained from one trial and a number of observational studies. This
review assessed the methodological quality of the trials included
and found that some important quality parameters were not ade-
quately addressed.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence from one trial suggests that face washing can be effective
in increasing facial cleanliness and in reducing severe trachoma, but
its effect in reducing active trachoma is inconclusive. In another
trial, there was no evidence of effect of face washing alone or
in combination with tetracycline in reducing active trachoma in
children with already established disease.
Implications for research
The trials included in this review evaluated the effect of face wash-
ing over a three to 12month period.However, it is unclear whether
this time period is long enough for a face washing promotional ac-
tivity to demonstrate impact of the intervention. Therefore, future
research should include longer follow-up periods and also address
the questions of whether reinforcement activities are required over
time to improve outcome. The reporting of the methodology of
trials should be complete to enable reviewers and readers to assess
the validity of their conclusions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Peach 1987
Methods 36 aboriginal communities were randomized in stages to four experimental groups after
stratification by geographical location
Method of randomization: not stated
Unit of randomization: communities, but individuals where analyzed
Masking: outcome assessors masked but method of masking unclear
Analysis was by intention-to-treat principle (participants lost to follow up were assumed to
have follicles at the end of the study)
Participants Country: Northern Territory of Australia
Participants: children aged five years and above drawn from 36 aboriginal communities
Age range: most participants were between 5 and 14 years, although a small proportion of
children were older than 14 and a small proportion were pre-school
Total number of children randomized: 1143
Interventions Treatment:
1. Tetracycline eye drops daily for one week every month for 3 months (374 children
randomized)
2. Eye washing daily for 3 months (246 children randomized)
3. Tetracycline eye drops plus eye washing (312 children randomized)
Control:
No treatment (211 children)
Outcomes Follicular trachoma (proportion of children with follicular trachoma at 3 months)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
West 1995
Methods Six villages were randomized in three pairs to intervention or control
Method of randomization: unclear
Masking: outcome assessors masked. Assessors examined photographs of tarsal plates for
follicles
Participants Country: Kongwa, Tanzania
Participants: Children aged 1 to 7 years drawn from 6 trachoma endemic villages
Total number of children randomized: 1417
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West 1995 (Continued)
Interventions Treatment:
Face washing promotion combined with mass tetracycline ointment (680 children)
Control:
Mass tetracycline ointment only (737 children). Tetracycline ointment was administered
topically once daily for 30 days
Outcomes 1. Active trachoma
2. Severe trachoma
3. Clean face
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Unclear
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Edwards 2006 Study intervention is health education promotion of face washing
Khandekar 2006 Unable to separate the effect of face washing from environmental sanitation interventions as both were indirectly
examined as “one intervention”
King 2011 Study aim was to develop standardized definition for a clean face in trachoma prevention
Rubinstein 2006 Study intervention is health education promotion of face washing
Sutter 1983 Not a randomized controlled trial
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D A T A A N D A N A L Y S E S
This review has no analyses.
A D D I T I O N A L T A B L E S
Table 1. Quality assessment
Trial ID Method randomiza-
tion
Allocation conceal. Baseline compar. Attrition Intention-to-treat
Peach 1987 Unclear risk Unclear risk Low risk Unclear risk Unclear risk
West 1995 Low risk ? Low risk Unclear risk Low risk Low risk
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Trachoma
#2 MeSH descriptor Chlamydia trachomatis
#3 (trachom*)
#4 (tracom*)
#5 (follicular near conjunctivitis)
#6 (intense near conjunctivitis)
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)
#8 MeSH descriptor Hygiene
#9 MeSH descriptor Face
#10 face-wash or facewash*
#11 face near wash*
#12 facial near wash*
#13 face near clean*
#14 facial near clean*
#15 face near hygien*
#16 facial near hygien*
#17 (#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)
#18 (#7 AND #17)
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Appendix 2. MEDLINE (OVID) search strategy
1 randomized controlled trial.pt.
2 (randomized or randomised).ab,ti.
3 placebo.ab,ti.
4 dt.fs.
5 randomly.ab,ti.
6 trial.ab,ti.
7 groups.ab,ti.
8 or/1-7
9 exp animals/
10 exp humans/
11 9 not (9 and 10)
12 8 not 11
13 exp trachoma/
14 exp chlamydia-trachomatis/
15 or/13-14
16 trac?oma$.tw.
17 (follicular adj3 conjunctivitis).tw.
18 (intense adj3 conjunctivitis).tw.
19 or/16-18
20 15 or 19
21 exp hygiene/
22 exp face/
23 or/21-22
24 ((face$ adj3 wash$) or clean$ or hygien$).tw.
25 ((facial adj3 wash$) or clean$ or hygien$).tw.
26 (face adj1 wash$).tw.
27 or/24-26
28 23 or 27
29 20 and 28
30 12 not 29
31 12 and 29
The search filter for trials at the beginning of the strategy is from the published paper by Glanville et al (Glanville 2006).
Appendix 3. EMBASE (OVID) search strategy
1 exp randomized controlled trial/
2 exp randomization/
3 exp double blind procedure/
4 exp single blind procedure/
5 random$.tw.
6 or/1-5
7 (animal or animal experiment).sh.
8 human.sh.
9 7 and 8
10 7 not 9
11 6 not 10
12 exp clinical trial/
13 (clin$ adj3 trial$).tw.
14 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15 exp placebo/
16 placebo$.tw.
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17 random$.tw.
18 exp experimental design/
19 exp crossover procedure/
20 exp control group/
21 exp latin square design/
22 or/12-21
23 22 not 10
24 23 not 11
25 exp comparative study/
26 exp evaluation/
27 exp prospective study/
28 (control$ or prospectiv$ or volunteer$).tw.
29 or/25-28
30 29 not 10
31 30 not (11 or 23)
32 11 or 24 or 31)
33 exp trachoma/
34 exp chlamydia-trachomatis/
35 or/33-34
36 trac?oma$.tw.
37 (follicular adj3 conjunctivitis).tw.
38 (intense adj3 conjunctivitis).tw.
39 or/36-38
40 35 or 39
41 exp personal hygiene/
42 exp face/
43 or/41-42
44 ((face$ adj3 wash$) or clean$ or hygien$).tw.
45 ((facial adj3 wash$) or clean$ or hygien$).tw.
46 (face adj1 wash$).tw.
47 or/44-46
48 43 or 47
49 40 and 48
50 32 and 49
Appendix 4. LILACS search strategy
trachoma$ and face or facial$ and wash$ or clean$ or hygien$
Appendix 5. metaRegister of Controlled Trials search strategy
(wash or clean or hygiene) and trachoma
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Appendix 6. ClinicalTrials.gov search strategy
(Wash OR Clean OR Hygiene) AND Trachoma
WH A T ’ S N E W
Last assessed as up-to-date: 2 September 2011.
Date Event Description
3 February 2012 New citation required but conclusions have not changed Issue 4, 2012: Risk of bias assessment has been amended
to reflect updated changes by The Cochrane Collabo-
ration
3 February 2012 New search has been performed Issue 4, 2012: Updated searches yielded no new studies
for inclusion
H I S T O R Y
Protocol first published: Issue 2, 2002
Review first published: Issue 3, 2004
Date Event Description
23 October 2008 Amended Converted to new review format.
20 February 2008 New search has been performed Issue 2 2008: three new trials were identified in an up-
dated search but were excluded
31 March 2004 New citation required and conclusions have changed Substantive amendment.
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